Ambu ASAMBBY 84 Gross Margin % is 60.27% as of Mar. 2026, which is 3% above its 10-year median of 58.71. GuruFocus rates AMBBY with a GF Score™ of 84/100 and a GF Value™ of $19.37 (Significantly Undervalued). Among 805 Medical Devices & Instruments companies, Ambu AS ranks better than 62.61% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Ambu AS's Gross Profit for the
three
months ended in Mar. 2026 was $146.6 Mil. Ambu AS's Revenue for the
three
months ended in Mar. 2026 was $243.3 Mil. Therefore, Ambu AS's Gross Margin % for the quarter that ended in Mar. 2026 was 60.27%.
The historical rank and industry rank for Ambu AS's Gross Margin % or its related term are showing as below:
AMBBY'
s Gross Margin % Range Over the Past 10 Years
Min: 53.93 Med: 58.71 Max: 62.37
Current: 59.98
During the past 13 years, the highestGross Margin % of Ambu AS was 62.37%. The lowest was 53.93%. And the median was 58.71%.
AMBBY's Gross Margin % is ranked better than 62.61% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs AMBBY: 59.98
Ambu AS had a gross margin of 60.27% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Ambu AS was -0.90% per year.
Ambu AS (OTCPK:AMBBY) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Ambu AS had a gross margin of 60.27% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Ambu AS Gross Margin % Related Terms
Ambu AS Gross Margin % Historical Data
* Premium members only.
The historical data trend for Ambu AS's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ambu AS's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambu AS Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Ambu AS's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Ambu AS (AMBBY) has a Gross Margin % of 60.27% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Ambu AS and its competitors. This is near median its historical median of 58.71. Over the past decade, Ambu AS's Gross Margin % has ranged from 53.93 to 62.37. According to the industry distribution chart, Ambu AS ranks #301 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 37.4%.
Is Ambu AS's Gross Margin % too high?
Ambu AS's current Gross Margin % of 60.27% is near median its 10-year median of 58.71. Over the past 10 years, this metric has ranged from a low of 53.93 to a high of 62.37. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Ambu AS's value of 60.27% is 15.7% above this industry median. Based on the distribution chart, Ambu AS ranks #301 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ambu AS has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ambu AS ranks #301 out of 805 companies for Gross Margin %. This puts Ambu AS in the upper half of its industry. The industry median Gross Margin % is 52.07. Ambu AS's value of 60.27% is 15.7% above this benchmark. Historically, Ambu AS's own Gross Margin % has ranged from 53.93 to 62.37 over the past decade. While the company's 10-year median is 58.71 vs. the industry median of 52.07, Ambu AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambu AS's current Gross Margin % of 60.27% is 15.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Ambu AS and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambu AS's current Gross Margin % is 60.27%, which is near median its own 10-year median of 58.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (AMBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.37, compared to a current price of $9.43 — trading 51.3% below its estimated fair value. The current Gross Margin % is 60.27%, which is near median its 10-year median of 58.71 and 15.7% above the Medical Devices & Instruments industry median of 52.07. Ambu AS's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Ambu AS (AMBBY), the current Gross Margin % is 60.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambu AS (AMBBY) Overvalued in 2026?
Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued.
The current stock price of $9.43 is trading 51.3% below its estimated GF Value™ of $19.37.
GuruFocus considers Ambu AS to be Significantly Undervalued.
Key valuation signals for AMBBY:
Gross Margin %: 60.27% (near median its 10-year median of 58.71)
GF Value™: $19.37 vs. price of $9.43 (51.3% below fair value)
Industry Position: 15.7% above the Medical Devices & Instruments median (#301 of 805)
No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
84GF Score
Get the complete analysis for AMBBY
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMBBY has been successfully added to your 
